Evofem Biosciences (NASDAQ:EVFM) Shares Cross Below Two Hundred Day Moving Average – Here’s Why

Evofem Biosciences, Inc. (NASDAQ:EVFM) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0087. Evofem Biosciences shares last traded at $0.0092, with a volume of 424,986 shares trading hands.

Evofem Biosciences Stock Performance

The firm has a market capitalization of $1.22 million, a price-to-earnings ratio of -0.01 and a beta of -1.41. The business has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01.

Evofem Biosciences Company Profile

Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.

The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.